AMD11070
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AMD11070, covering 2014-02-11 to 2021-11-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients [Phase 1, Phase 2]